Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
MedTech
Lumexa Imaging eyes IPO expected to raise $200M
Lumexa Imaging, known as US Radiology Specialists until this year, has filed with the SEC to go public and is set to raise as much as $200 million.
Joseph Keenan
Nov 19, 2025 12:28pm
DNA test maker BillionToOne raises $314M in IPO, shares dip
Nov 10, 2025 8:45am
MapLight goes public via $250M IPO to fund Cobenfy competitor
Oct 27, 2025 6:45am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
LB Pharmaceuticals eyes $228M in IPO cash
Sep 8, 2025 3:16pm